Machine Learning-based Prognostic Model for Brain Metastasis Patients: Insights from Blood Test Analysis
2025

Machine Learning Prognostic Model for Brain Metastasis Patients

Sample size: 1385 publication 10 minutes Evidence: high

Author Information

Author(s): Li Ruidan, Liu Zheran, Wei Zhigong, Huang Rendong, Pei Yiyan, Yang Jing, Qin Zijian, Li Huilin, Fang Fang, Peng Xingchen

Primary Institution: West China Hospital, Sichuan University

Hypothesis

Can machine learning improve prognostic predictions for brain metastasis patients using blood test parameters?

Conclusion

Integrating blood test parameters into the GPA model significantly improves prognostic predictions for brain metastasis patients.

Supporting Evidence

  • Model-HP showed superior performance with an AUC of 0.71 compared to other models.
  • Model-GPAH significantly enhanced prognosis prediction compared to GPA alone.
  • High-risk patients identified by Model-GPAH had significantly poorer overall survival.

Takeaway

Doctors can use blood tests to better predict how brain cancer patients will do, helping them choose the best treatments.

Methodology

Data from blood tests of brain metastasis patients were analyzed using machine learning models including Cox regression and random survival forest.

Potential Biases

Potential selection bias and residual confounding due to the retrospective design.

Limitations

The study is retrospective and conducted at a single institution, which may limit the generalizability of the findings.

Participant Demographics

The cohort included 1385 patients, predominantly lung cancer patients (78%), with a mix of genders and ages.

Statistical Information

P-Value

p<0.0001

Confidence Interval

[0.66, 0.77]

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.7150/jca.103847

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication